STEINMAN LAWRENCE

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$84,466.00
Insider Sells Quantity
6
Insider Sells Sum
$660,986.02

Insider Activity of STEINMAN LAWRENCE

According to the SEC Form 4 filings, STEINMAN LAWRENCE, being in a position of

  1. director at BioAtla, Inc.,
    оver the last 12 months, has bought 20000 shares for $41,048, and sold 0 shares,
    over all time since 2021-07-15, has bought 20000 shares for $41,048, and sold 3600 shares for $131,139.

The largest purchase of all time was on 2023-12-19 and amounted to 20000 shares of BioAtla, Inc. for $41,048.

The largest sale of all time was on 2005-03-02 and amounted to 8000 shares of Neurocrine Biosciences, Inc. for $328,829.

Biography of STEINMAN LAWRENCE

No biography is available at this moment.

2023-12-19PurchaseBioAtla, Inc.
BCAB
director
20,000
0.0427%
$2.05$41,048+7.29%
2023-06-01Purchase180 Life Sciences Corp.
ATNF
director
18,000
0.4949%
$1.23$22,068-75.14%
2021-12-09Purchase180 Life Sciences Corp.
ATNF
director
5,000
15.7263%
$4.27$21,350-68.88%
2021-11-02SaleBioAtla, Inc.
BCAB
director
900
0.0027%
$30.00$27,000-77.38%
2021-09-15SaleBioAtla, Inc.
BCAB
director
900
0.0027%
$36.82$33,138-79.67%
2021-08-16SaleBioAtla, Inc.
BCAB
director
900
0.0027%
$40.60$36,540-81.26%
2021-07-15SaleBioAtla, Inc.
BCAB
director
900
0.0027%
$38.29$34,461-64.62%
2005-03-02SaleNeurocrine Biosciences, Inc.
NBIX
director
8,000
0.0221%
$41.10$328,829+15.69%
2004-09-15SaleNeurocrine Biosciences, Inc.
NBIX
director
4,000
0.0108%
$50.25$201,018-11.12%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.